ifezuntirgene inilparvovec (AMT-130) — Topline data
Sep 2026
In September 2026, the Company plans to present data from its ongoing Phase I/II studies of AMT-130.Source filing
QURE biotech catalysts & pipeline
UNIQURE NV · Data as of 2026-09-08
Upcoming catalysts
AMT-260 — Interim data
H1 2027
uniQure expects to present updated results from the Phase I/IIa clinical trial in the first half of 2027.Source filing